Overview

The Study of Efficacy and Safety of Dimephosphon in Acute Ischemic Stroke

Status:
RECRUITING
Trial end date:
2026-04-30
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon in acute ischemic stroke
Phase:
PHASE3
Details
Lead Sponsor:
Tatchempharmpreparaty, JSC
Treatments:
dimephosphon